Intestinal inflammation and seizure susceptibility: Understanding the role of tumour necrosis factor-α in a rat model

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 10, 2009, Pages 1359-1364

  Medhi, Bikash ^a   Prakash, Ajay ^a   Avti, Pramod K ^a   Chakrabarti, Amitava ^a   Khanduja, Krishan L ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Colitis; Seizure; Thalidomide; TNBS

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PENTETRAZOLE; SUPEROXIDE DISMUTASE; THALIDOMIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; COLITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; NONHUMAN; RAT; SEIZURE; SEIZURE SUSCEPTIBILITY; TREATMENT DURATION; ANIMAL; BLOOD; BRAIN; CHEMICALLY INDUCED DISORDER; COLON; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BRAIN; CATALASE; COLITIS; COLON; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; MALE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; SEIZURES; SUPEROXIDE DISMUTASE; THALIDOMIDE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85047681880     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.10.0013     Document Type: Article

References (35)

1. Akhan G et al. Ulcerative colitis, status epilepticus and intractable temporal seizures. Epileptic Disord 2002; 4: 135-137.
2. Virta M et al. Increased plasma levels of pro and antiinflammatory cytokines in patients with febrile seizures. Epilepsia 2002; 43: 920-923.
3. Muñoz-Fernandez MA, Fresno M. The role of tumor necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 1998; 56: 307-340.
4. Lisak RP et al. Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures. J Neuroinflammation 2009; 6: 4.
5. De Simoni MG et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000; 12: 2623-2633.
6. Pan W et al. Tumour necrosis factor a: a neuromodulator in the CNS. Neurosci Biobehav Rev 1997; 21: 603-613.
7. Rao RS et al. Experimentally induced various inflammatory models and seizure: understanding the role of cytokine in rat. Eur Neuropsychopharmacol 2008; 18: 760-767.
8. Van Luijetalaar ELJM et al. The influence of interleukins 1-β and TNF-α in spice-ware discharges in a genetic model of absence epilepsy. Conference of the Ukranian Association of Absence Epilepsy, Odessa 2001: 32-38.
9. Palencia G et al. Thalidomide inhibits pentylenetetrazoleinduced seizures. J Neurol Sci 2007; 258: 128-131.
10. Rizzi M et al. Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis 2003; 14: 494-503.
11. De Simoni MG et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000; 12: 2623-2633.
12. Prakash O et al. Effect of different doses of thalidomide in experimentally induced inflammatory bowel disease in rats. Basic Clin Pharmacol Toxicol 2008; 103: 9-16.
13. Amaral ME et al. Tumor necrosis factor-alpha activates signal transduction in hypothalamus and modulates the expression of pro-inflammatory proteins and orexigenic/anorexigenic neurotransmitters. J Neurochem 2006; 98: 203-212.
14. Kono Y. Generation of superoxide radical during auto-oxidation of hydroxylamine and assay for SOD. Arch Biochem Biophys 1978; 186: 189-195.
15. Luck H. Catalase. In: Bergmeyer HW, ed. Methods of Enzymatic Analysis. New York: Academic Press, 1963: 885-894.
16. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 701: 158-169.
17. Ohkawa H et al. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
18. Gerhard VH, Goethe JW. Experimental colitis. In: Vogel H, ed. Drug Discovery and Evaluation: Pharmacological Assays, 2nd edn. Germany: Springer, 2002: 896-899.
19. Bernardino L et al. Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J Neurosci 2005; 25: 6734-6744.
20. Yuhas Y et al. Involvement of tumor necrosis factor alpha and interleukin-1beta in enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae. Infect Immun 1999; 67: 1455-1460.
21. Chao CC et al. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 1995; 9: 355-365.
22. Hathaway CA et al. Effects of free radicals and leukocytes on increases in blood-brain barrier permeability during colitis. Dig Dis Sci 2000; 45: 967-975.
23. Hathaway CA et al. Experimental colitis increases blood-brain barrier permeability in rabbits. Am J Physiol Gastrointest Liver Physiol 1999; 276: 1174-1180.
24. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut 2000; 47: 861-869.
25. De Vries HE et al. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 1996; 64: 37-44.
26. McHugh KJ et al. Exudative and absorptive permeability in different phases of an experimental colitis condition. Scand J Gastroenterol 1996; 31: 900-905.
27. Hollander D. Inflammatory bowel diseases and brain-gut axis. J Physiol Pharmacol 2003; 54(Suppl. 4): 183-190.
28. Pluzanska A. Recombinant human tumor necrosis factor alpha (TNF): preclinical studies and results of early clinical trials. Acta Haematol Pol 1994; 25(2 Suppl. 1): 148-154.
29. Dunn AJ. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci 1988; 43: 429-435.
30. Vezzani A et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA 2000; 97: 11534-11539.
31. Ravizza T, Vezzani A. Status epilepticus induces timedependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience 2006; 137: 301-308.
32. Ko JK et al. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol 2005; 11: 5787-5794.
33. Girgin F et al. Effects of trimetazidine on oxidant/antioxidant status in trinitrobenzenesulfonic acid induced chronic colitis. J Toxicol Environ Health A 2000; 59: 641-652.
34. Grisham MB, Granger DN. Neutrophil-mediated mucosal injury: role of reactive oxygen metabolites. Dis Dig Sci 1988; 33: 6s-15s.
35. Verspaget HW et al. Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut 1988; 29: 223-228.